Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Chien KS"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gener-Ricos G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Quesada AE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Almanza-Huante E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2024 Oct 15; Vol. 130 (20), pp. 3452-3462. Date of Electronic Publication: 2024 Jun 19.
Autor:
McCall D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: dmccall1@mdanderson.org., Abuasab T; Department of Medicine, Baylor University, Houston, TX, USA., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mohamed SF; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Patnaik A; McGovern Medical School, University of Texas Health Sciences Center at Houston (UTHealth), Houston, TX, USA., Devireddy K; McGovern Medical School, University of Texas Health Sciences Center at Houston (UTHealth), Houston, TX, USA., Arani N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sheikh I; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jamshidi R; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Gibson A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nuñez C; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cuglievan B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia research [Leuk Res] 2024 Sep; Vol. 144, pp. 107563. Date of Electronic Publication: 2024 Aug 20.
Autor:
Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 Sep; Vol. 22 (7), pp. 320-327.
Autor:
Marvin-Peek J; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, jmarvin@mdanderson.org., Shelton V; Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Brassil K; Pack Health, A Quest Diagnostics Company, Birmingham, Alabama, USA., Fellman B; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Barr A; Pack Health, A Quest Diagnostics Company, Birmingham, Alabama, USA., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Swaminathan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Acta haematologica [Acta Haematol] 2024 Jun 11, pp. 1-10. Date of Electronic Publication: 2024 Jun 11.
Autor:
Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Gener-Ricos G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Almanza-Huante E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Urrutia S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2695-2706.
Autor:
Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Dinardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Nasr LF; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Macaron W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Nasnas C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX., Matthews J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Stojanik CJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Abramova R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Thankachan J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 01; Vol. 42 (13), pp. 1499-1508. Date of Electronic Publication: 2024 Jan 26.
Autor:
Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Desikan SP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Venugopal S; Department of Leukemia, The University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida., Urrutia S; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 01; Vol. 30 (7), pp. 1319-1326.
Autor:
Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ong F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kim K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7093.
Autor:
Chiu CY; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., Matsuo T; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., Wurster S; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., Gerstein Y; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., Hammond DE; Department of Leukaemia, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., Chien KS; Department of Leukaemia, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., DiNardo C; Department of Leukaemia, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA., Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Centre, Houston, Texas, USA.
Publikováno v:
Mycoses [Mycoses] 2023 Dec; Vol. 66 (12), pp. 1029-1034. Date of Electronic Publication: 2023 Aug 07.